Can I prescribe diazepam for muscle spasms in a patient taking Aptiom (eslicarbazepine acetate)?

Can You Prescribe Diazepam for Muscle Spasms in a Patient Taking Aptiom (Eslicarbazepine Acetate)?

Yes, you can prescribe diazepam for muscle spasms in a patient taking Aptiom (eslicarbazepine acetate), as there are no documented contraindications or significant drug-drug interactions between these medications. However, you must closely monitor for additive central nervous system (CNS) depression and counsel the patient about increased sedation risk.

Drug Interaction Assessment

The FDA label for Aptiom 1 does not list diazepam or benzodiazepines as contraindicated medications or as having clinically significant interactions. The label specifically mentions drug interactions with phenobarbital, carbamazepine, phenytoin, simvastatin, birth control medicines, omeprazole, rosuvastatin, clobazam, and primidone—but notably excludes benzodiazepines like diazepam from this list.

The diazepam FDA label 2 confirms its indication for "relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome."

Clinical Efficacy for Muscle Spasms

Diazepam has demonstrated efficacy for muscle spasm in specific contexts:

• For skeletal muscle spasm with pain: Case reports show diazepam provides an opioid-sparing effect and superior symptomatic relief when added to morphine for severe back pain with muscle spasm from vertebral metastases 3
• For reflex cervical muscle spasm: Double-blind studies using electrogoniometric and EMG recordings showed statistically significant benefits of diazepam compared to phenobarbital or placebo 4
• For spasticity: Diazepam reduces phasic ankle reflexes in spasticity at plasma concentrations of 300-2,200 mg/L, though drowsiness occurs at these levels 5

Critical Safety Considerations

CNS Depression Warning

Both medications can cause CNS side effects:

• Aptiom: dizziness, sleepiness, feeling tired, trouble concentrating, trouble walking/coordination, vision problems 1
• Diazepam: drowsiness, light-headedness, dizziness, sedation 2

The combination will likely produce additive sedation. You must explicitly warn patients not to drive or operate machinery until they know how the combination affects them.

Monitoring Requirements from Aptiom Label

Watch for Aptiom-specific concerns that could be worsened by adding a sedating medication 1:

• Low sodium levels (hyponatremia)—symptoms include nausea, confusion, more frequent seizures
• Suicidal thoughts or behavior changes
• Allergic reactions affecting liver or blood cells

Short-Term Use Only

The diazepam label 2 states: "The effectiveness of diazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies." For muscle spasms, limit duration to weeks, not months.

Evidence Limitations

Research on benzodiazepines for muscle-related pain shows concerning findings:

• In rheumatoid arthritis patients, diazepam showed no significant benefit over placebo for pain at 24 hours, 1 week, or 2 weeks 6
• Short-term use (24 hours to 2 weeks) was associated with significant adverse events, predominantly drowsiness and dizziness (NNTH 3,95% CI 2 to 7) 6

However, these studies focused on RA pain rather than acute muscle spasm from local pathology, which is the FDA-approved indication.

Practical Prescribing Algorithm

1. Confirm the indication: Acute muscle spasm from local pathology (trauma, inflammation) or spasticity from upper motor neuron disorders
2. Start low: Diazepam 2-5 mg PO 2-3 times daily initially
3. Counsel explicitly: No driving, no alcohol, expect increased drowsiness beyond baseline Aptiom effects
4. Monitor sodium: Check serum sodium if patient develops confusion or increased seizures (Aptiom can cause hyponatremia)
5. Limit duration: Plan for 1-2 weeks maximum; reassess need at follow-up
6. Taper if used >1 week: Do not stop abruptly to avoid withdrawal

Common Pitfalls to Avoid

• Don't prescribe for chronic muscle pain: Evidence doesn't support efficacy beyond 2 weeks, and dependence risk increases
• Don't ignore baseline sedation: If patient already experiences significant drowsiness from Aptiom, consider non-sedating alternatives (physical therapy, topical agents, NSAIDs)
• Don't forget contraception counseling: Aptiom reduces birth control efficacy 1; adding a sedating medication that impairs judgment increases pregnancy risk
• Don't overlook alcohol use: Combined CNS depression with alcohol can be dangerous

The combination is pharmacologically safe from a drug-drug interaction standpoint, but requires careful patient selection and monitoring for additive CNS effects.